• DLBCL Specialist

 Leslie L. Popplewell, M.D., is the principal investigator for a number of clinical trials examining new lymphoma therapies including CAR T cells and phase 1 and first in human trials. She is also working on advanced transplant techniques for patients whose lymphoma has recurred.

Dr. Popplewell received her medical degree from the University of Louisville School of Medicine. She joined City of Hope in 1998 following a fellowship at the renowned Memorial Sloan Kettering Cancer Center in New York City.